Yes, looks like GERN will need that capital raise within a year. However I still like the potential of their drug Imetelstat, and I think it could be a blockbuster cancer drug yet. Unfortunately I will have to wait another year or so for FDA approval. In the meantime, my hope is a pharma company will get involved, and pay for expenses along the way. My plan is to add should it keep trending down towards the $2 area.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.